Pfizer Settles Foreign Bribery Charges, Wins Deferred Prosecution For Helping Government
This article was originally published in PharmAsia News
Pfizer reaches separate settlements with U.S. DoJ and SEC to resolve charges its subsidiaries bribed Chinese, Russian and other foreign government officials; a subsidiary enters a deferred prosecution agreement with DoJ.
You may also be interested in...
A Pfizer attorney says government saber rattling over individual liability does not mean there will be a spike in individual prosecutions; Pfizer’s cooperation with the government helped it avoid criminal resolution in a Foreign Corrupt Practices Act settlement.
Johnson & Johnson agreed to pay $70 million to resolve charges by the Securities and Exchange Commission and the Department of Justice that the company bribed doctors in several European countries to order or prescribe its products in violation of the Foreign Corrupt Practices Act
Complaint lists host of problems with implementation of the rule that allows states to sponsor programs to import certain prescription drugs from Canada; at least six states have enacted legislation to sponsor these programs.